Lux Health Tech Acquisition Corp.

Lux Health Tech Acquisition Corp. (Nasdaq: LUXA) is a blank-check company formed to pursue a business combination in the health technology sector. The SPAC completed its initial public offering in 2021, with Lux Health Tech Sponsor LLC serving as the affiliated sponsor entity. In September 2022, the company filed a preliminary proxy amendment (Form PRER14A) with the Securities and Exchange Commission, indicating it was in the process of seeking shareholder approval — a standard procedural step as SPACs advance toward a merger vote or extension of their combination window. LUXA's deal activity placed it among the health-tech-focused acquisition vehicles active during the 2021–2022 SPAC cycle. For comprehensive deal timelines, proxy details, filing history, and target data on LUXA and thousands of other SPACs, create a free account at SpacDesk.